PETMED EXPRESS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
PETMED EXPRESS, INC. (PETS) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $203.00 thousand for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-02.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-06-02
- PETMED EXPRESS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for the quarter ending 2025-03-31 was $29.00K.
- PETMED EXPRESS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for the quarter ending 2024-12-31 was -$1.80M.
- PETMED EXPRESS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for the quarter ending 2024-09-30 was -$1.80M.
- PETMED EXPRESS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for the quarter ending 2024-06-30 was -$1.80M.
- PETMED EXPRESS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2026 was $203.00K.
- PETMED EXPRESS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was -$1.77M, a 200.00% decline from fiscal 2024.
- PETMED EXPRESS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $1.77M.
- PETMED EXPRESS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $0.00.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 6 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 9 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|---|---|---|
| 2026-03-31 | $203.00K 10-K · filed 2026-06-02 | |||
| 2025-03-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-14 | -$1.77M derived: sum of 2 quarters · filed 2025-10-14 | -$3.57M derived: sum of 3 quarters · filed 2025-10-14 | -$1.77M 10-K · filed 2025-10-14 |
| 2024-12-31 | -$1.80M 10-Q · filed 2025-02-10 | -$3.60M derived: sum of 2 quarters · filed 2025-02-10 | -$1.80M 10-Q · filed 2025-02-10 | |
| 2024-09-30 | -$1.80M 10-Q · filed 2024-11-07 | -$1.80M 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | -$1.80M 10-Q · filed 2024-08-07 | |||
| 2024-03-31 | $1.77M 10-K · filed 2025-10-14 | |||
| 2023-03-31 | $0.00 10-K · filed 2025-10-14 | |||
| 2022-03-31 | $0.00 10-K · filed 2024-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS HEALTH Corp (CVS) | United States | $108.783B | 27.06 |